These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2502615)

  • 81. Comment: topical mupirocin.
    Pappa KA
    Drug Intell Clin Pharm; 1987 May; 21(5):466. PubMed ID: 3107962
    [No Abstract]   [Full Text] [Related]  

  • 82. Retapamulin for impetigo and other infections.
    Drug Ther Bull; 2008 Oct; 46(10):76-9. PubMed ID: 18832258
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Innovation and development in oral and topical antibiotics.
    Crook SJ
    Practitioner; 1986 Mar; 230(1413):249-56. PubMed ID: 3086858
    [No Abstract]   [Full Text] [Related]  

  • 84. Ozenoxacin 1% cream (Xepi) for impetigo.
    Med Lett Drugs Ther; 2019 Apr; 61(1570):63-64. PubMed ID: 31169810
    [No Abstract]   [Full Text] [Related]  

  • 85. Unique approaches for the topical treatment and prevention of cutaneous infections: report from a clinical roundtable.
    Eichenfield LF; Carney PS; Chow MJ; Tal A; Weinberg JM; Yurko M
    Cutis; 2004 Aug; 74(2 Suppl):2-23. PubMed ID: 15377080
    [No Abstract]   [Full Text] [Related]  

  • 86. A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily infected traumatic lesions and impetigo due to methicillin-resistant Staphylococcus aureus.
    Tanus T; Scangarella-Oman NE; Dalessandro M; Li G; Breton JJ; Tomayko JF
    Adv Skin Wound Care; 2014 Dec; 27(12):548-59. PubMed ID: 25396674
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study.
    Oranje AP; Chosidow O; Sacchidanand S; Todd G; Singh K; Scangarella N; Shawar R; Twynholm M;
    Dermatology; 2007; 215(4):331-40. PubMed ID: 17911992
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials.
    Hebert AA; Albareda N; Rosen T; Torrelo A; Grimalt R; Rosenberg N; Zsolt I; Masramon X
    J Drugs Dermatol; 2018 Oct; 17(10):1051-1057. PubMed ID: 30365584
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Mupirocin: pharmacology and therapeutic indications].
    Geoffray C; Chosidow O; Revuz J
    Ann Dermatol Venereol; 1990; 117(10):753-7. PubMed ID: 2127340
    [No Abstract]   [Full Text] [Related]  

  • 90. Impetigo update: new challenges in the era of methicillin resistance.
    Geria AN; Schwartz RA
    Cutis; 2010 Feb; 85(2):65-70. PubMed ID: 20349679
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema.
    Rist T; Parish LC; Capin LR; Sulica V; Bushnell WD; Cupo MA
    Clin Exp Dermatol; 2002 Jan; 27(1):14-20. PubMed ID: 11952661
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ozenoxacin, a New Effective and Safe Topical Treatment for Impetigo in Children and Adolescents.
    Torrelo A; Grimalt R; Masramon X; Albareda López N; Zsolt I
    Dermatology; 2020; 236(3):199-207. PubMed ID: 31958794
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.
    Jacobs MR
    Future Microbiol; 2007 Dec; 2(6):591-600. PubMed ID: 18041900
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Ozenoxacin: A Novel Topical Quinolone for Impetigo.
    Wren C; Bell E; Eiland LS
    Ann Pharmacother; 2018 Dec; 52(12):1233-1237. PubMed ID: 29962213
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial.
    Rosen T; Albareda N; Rosenberg N; Alonso FG; Roth S; Zsolt I; Hebert AA
    JAMA Dermatol; 2018 Jul; 154(7):806-813. PubMed ID: 29898217
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Impetigo].
    Mazereeuw-Hautier J
    Ann Dermatol Venereol; 2006 Feb; 133(2):194-207. PubMed ID: 16508614
    [No Abstract]   [Full Text] [Related]  

  • 97. Update on topical antibiotics in dermatology.
    Drucker CR
    Dermatol Ther; 2012; 25(1):6-11. PubMed ID: 22591495
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Mupirocin-resistant Staphylococcus aureus.
    Cookson BD; Lacey RW; Noble WC; Reeves DS; Wise R; Redhead RJ
    Lancet; 1990 May; 335(8697):1095-6. PubMed ID: 1970392
    [No Abstract]   [Full Text] [Related]  

  • 99. Comparative double-blinded study between mupirocin and tetracycline ointments for treating skin infections.
    Wong KS; Lim KB; Tham SN; Ling ML; Tan T
    Singapore Med J; 1989 Aug; 30(4):380-3. PubMed ID: 2510312
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Formaldehyde as an alternative to antibiotics for treatment of refractory impetigo and other infectious skin diseases.
    Nikolic P; Mudgil P; Whitehall J
    Expert Rev Anti Infect Ther; 2019 Sep; 17(9):681-687. PubMed ID: 31393185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.